Track Vitrolife AB (publ) — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Vitrolife AB (publ) VITR.ST Open Vitrolife AB (publ) in new tab

104.30 SEK
P/E
37.14
EPS
-37.01
P/B
1.75
ROE
-47.27
Beta
1.73
Target Price
172.20 SEK
Loading chart...
Key Metrics
Earnings dateJuly 16, 2026
P/E37.14
EPS-37.01
Book Value59.58
Price to Book1.75
Debt/Equity19.60
% Insiders29.715%
Growth
Revenue Growth-0.04%
Earnings Growth0.00%
Estimates
Forward P/E21.62
Forward EPS4.81
Target Mean Price172.20

DCF Valuation

Tweak assumptions to recompute fair value for Vitrolife AB (publ) (VITR.ST)
Currency: SEK
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Vitrolife AB (publ) Logo Vitrolife AB (publ) Analysis (VITR.ST)

Sweden Health Care Official Website Stock

Is Vitrolife AB (publ) a good investment? Vitrolife AB (publ) (VITR.ST) is currently trading at 104.30 SEK. Market analysts have a consensus price target of 172.20 SEK. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 37.14. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Vitrolife AB (publ) is expected to release its next earnings report on July 16, 2026. The market consensus estimate for Forward EPS is 4.81.

Investor FAQ

Does Vitrolife AB (publ) pay a dividend?

No, it does not currently pay a dividend.

What asset class is Vitrolife AB (publ)?

Vitrolife AB (publ) is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be July 16, 2026. The company currently has a trailing EPS of -37.01.

Company Profile

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

Exchange Ticker
STO (Sweden) VITR.ST
FRA (Germany) VTFN.F
Historical Dividends
Year Total Dividends
2026 1.10 SEK
2025 1.10 SEK
2024 1.00 SEK
2023 0.85 SEK
2022 0.80 SEK
2021 0.80 SEK
2019 0.85 SEK
2018 3.70 SEK
2017 2.60 SEK
2016 2.40 SEK
2015 1.50 SEK
2014 1.00 SEK
2013 0.60 SEK
2012 0.60 SEK
2011 0.60 SEK
2010 0.50 SEK
2009 0.40 SEK

Yearly aggregated dividends

Dividends

Vitrolife AB (publ)
May 12, 2026 Paid
Dividend
1.1 SEK

Historical Split Corporate Actions

Split Date Split Ratio to 1
May 17, 2018 5.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion